Bromomethane

Bromomethane

SCHEMBL6416803

[2H]C([2H])([2H])Br

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromomethane SCHEMBL13032077 0.83
Bromomethane SCHEMBL1744 0.71
Bromomethane SCHEMBL2981823 0.71
Bromomethane SCHEMBL17770700 0.71
Bromomethane SCHEMBL3738968 0.71
Bromomethane SCHEMBL11584708 0.61
Bromomethane SCHEMBL10615072 0.61
Bromomethane SCHEMBL42155 0.61
Bromomethane SCHEMBL8720231 0.61
Bromomethane SCHEMBL9703636 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118619811-A Preparation method and purification method of tert-butyl alcohol-d 9 宁波萃英化学技术有限公司 2024-09-10 CN disclosed
CN-109641849-B Synthesis method of deuterated dextromethorphan 雅芳制药公司 2022-06-14 CN disclosed
US-8324229-B2 Alkylthio pyrimidines as CRTH2 antagonists ACTIMIS PHARMACEUTICALS, INC. (US) 2012-12-04 US disclosed
US-8076330-B2 Dipeptidyl peptidase-IV inhibitors AMGEN INC. (US) 2011-12-13 US disclosed
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2011-05-12 US disclosed
US-20100298361-A1 Alkylthio Pyrimidines As CRTH2 Antagonists GB005, INC. 2010-11-25 US disclosed
US-7834031-B2 Radiolabeled glycine transporter inhibitors MERCK SHARP & DOHME CORP. (US) 2010-11-16 US disclosed
US-20100009961-A1 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2010-01-14 US disclosed
US-20090269278-A1 Radiolabeled Glycine Trasporter Inhibitors MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-7553861-B2 Dipeptidyl peptidase-IV inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2009-06-30 US disclosed
US-20090062325-A1 DEUTERIUM-ENRICHED TIOTROPIUM PROTIA, LLC (US) 2009-03-05 US disclosed
US-7365091-B2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX ENOBIA PHARMA (CA) 2008-04-29 US disclosed
US-20070060618-A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding MERCK & CO., INC. (US) 2007-03-15 US disclosed
US-20050053552-A1 Phase shift colloids as ultrasound contrast agents QUAY STEVEN C (US) 2005-03-10 US disclosed
US-6569404-B1 Aqueous colloidal suspension, dispersed phase is gas microbubbles of perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane or sulfur hexafluoride; fluorinated amphiphile for stabilizing microbubbles AMERSHAM HEALTH A/S (NO) 2003-05-27 US disclosed
US-6245319-B1 Colloidal dispersions of perfluoropentane SONUS PHARMACEUTICALS, INC. 2001-06-12 US disclosed
EP-0680341-B1 PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS SONUS PHARMA INC (US) 2001-05-09 EP disclosed
EP-1038535-A2 Use of selected perfluorocarbons for the preparation of diagnostic ultrasound contrast agents SONUS PHARMACEUTICALS, INC. (US) 2000-09-27 EP disclosed